Cite

HARVARD Citation

    Thomson, D. et al. (n.d.). Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck. Head & neck. 37 (2), pp. 182-187. [Online]. 
  
Back to record